期刊文献+

飞燕草素联合3-MA增敏抗HER-2阳性乳腺癌细胞效应 被引量:3

Delphinidin sensitizes anti-tumor effect to HER-2+breast cancer cells by combining with 3-MA
下载PDF
导出
摘要 目的:研究飞燕草素(delphinidin,Dp)联合自噬抑制剂3-甲基腺嘌呤(3-Methyladnine,3-MA)对HER-2+乳腺癌细胞MDA-MB-453的抑制效应。方法:用不同浓度飞燕草素处理MDA-MB-453细胞,CCK-8检测细胞增殖情况;荧光斑点实验和Weston Blot实验检测飞燕草素对细胞自噬的诱导情况;Weston Blot实验检测3-MA对自噬的抑制状况,CCK-8检测飞燕草素联合3-MA对细胞增殖状况的影响。结果:飞燕草素能有效抑制MDA-MB-453细胞增殖,诱导MDA-MB-453细胞自噬并呈剂量依赖效应;3-MA有效抑制MDA-MB-453细胞自噬,同时增强自噬飞燕草素抗HER-2+乳腺癌细胞MDA-MB-453增殖效应。结论:飞燕草素联合自噬抑制剂3-MA,能促进飞燕草素抗HER-2+乳腺癌细胞MDA-MB-453增殖。 Objective: To research the effect of delphinidin ( Dp ) combines with 3 - Methyladnine (3 - MA), inhibitor of autophagy,to HER( human epidermal growth factor receptor-2, HER-2)positive breast cancer cell MDA-MB-453.Methods: HER-2 ^+ breast cancer cells MDA-MB-453 were treated by Dp.Proliferation of MDA-MB-453 cells was detected by CCK-8. Fluorescenc, e dot assay and Weston Blot were used to identify autophagy in breast cancer cells.Weston blot was used to assay condition of autophagy inhibition of 3-MA to MDA-MB-453 cell and CCK-8 tests combination effect of Dp and 3-MA to MDA-MB-453 cell.Results:Dp suppressed proliferation effectively and induced autophagy in dose-dependent manner in MDA -MB-453 cells.However,3-MA could restrain the autophagy, which sensitized anti-proliferation of Dp to MDA-MB-453 cell.Conclusion: Combination of Dp and 3-MA which suppresses autophagy can sensitize anti-proliferation effect of HER-2 ^+ breast caneer cell MDA-MB-453.
出处 《食品工业科技》 CAS CSCD 北大核心 2017年第2期354-357,373,共5页 Science and Technology of Food Industry
基金 国家自然科学基金(81573154) 国家自然科学基金(81273074) 四川省省属高校科研创新团队项目(14TD0023) 四川省青年科技创新研究团队项目(2014TD0021)
关键词 飞燕草素 乳腺癌 自噬 增敏 delphinidin breast cancer autophagy sensibilization
  • 相关文献

参考文献1

二级参考文献26

  • 1常徽,糜漫天,凌文华.黑米花色苷及联合化疗药物对不同肿瘤细胞增殖的影响[J].第三军医大学学报,2007,29(20):1943-1946. 被引量:16
  • 2Meng XY, Zhang HX, Mezei M, et al. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des, 2011, 7(2): 146-157.
  • 3De Azevedo WF. MolDock applied to structure-based virtual screening. Curr Drug Targets, 2010, 11(3): 327-334.
  • 4Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem, 2006, 49(11): 3315-3321.
  • 5Nahta R, Shabaya S, Ozbay T. Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens. Curr Pharmac Person Med, 2009, 7(4): 263-274.
  • 6Tuba O, Rita N. Delphinidin inhibits HER2 and Erkl/2 signaling and suppresses growth of HER2- overexpressing and triple negative breast cancer cell lines. Breast Cancer: Basic Clin Res, 2011, 5: 143-154.
  • 7Fridrich D, Teller N, Esselen M. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3- gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Mol Nutr Food Res 2008, 52: 815-822.
  • 8Wang LS, Carmella S, Keyes R, et al. Anthocyanins and cancer prevention//Sarkar FH Ed. Nutraceuticals and Cancer. Springer Science Business Media BV, 2012.
  • 9Aertgeerts K, Skene R, Yano J, et al. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem, 2011, 286(21): 18756-18765.
  • 10Shaikh F, Sanehi P, Rawal R. Molecular screening of compounds to the predicted protein-protein interaction site of Rbl-E7 with p53-E6 in HPV. Bioinformation, 2012, 8(13): 607-612.

共引文献5

同被引文献32

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部